EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Effect of crocin versus fluoxetine in treatment of mild to moderate obsessive‐compulsive disorder: A double blind randomized clinical trial

Fatemeh Kazemi, Iraj Vosough, Samaneh Sepahi, Seyed Ahmad Mohajeri iD

Human Psychopharmacology: Clinical and Experimental · 2021-07 · 36 (4)

DOI: 10.1002/hup.2780 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Human Psychopharmacology: Clinical and Experimental, online erschienen am 18.02.2021. Verfasst von Fatemeh Kazemi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Fluoxetine, Obsessive-Compulsive Disorder. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Mashhad University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Obsessive‐compulsive disorder (OCD) is a common disabling disorder. Crocin, the active component of the saffron plant (Crocus Sativus L.) has various pharmacological activities. The present study compared the efficacy and safety of crocin and fluoxetine in treatment of mild to moderate OCD. Methods & Materials Fifty patients with OCD, aged 18 to 60 years, were randomized to receive either crocin (15 mg) or fluoxetine (20 mg) capsules for 8 weeks. Eligible participants received one capsule/day in the first month, which followed by two capsules daily in the second month. The patients were evaluated using Yale‐Brown Obsessive‐compulsive scale (Y‐BOCS) and Hamilton Anxiety Rating scale (HARS).

Results

The mean Y‐BOCS score in both groups decreased significantly during 2 months ( p ‐value = 0.0001). Also, HARS score in the crocin group was changed from 17.16 to 13.04 whereas, in the fluoxetine group was decreased from 18.28 to 12.34. The results indicated no difference between the two groups in Y‐BOCS and HARS score changes after 2‐month trial ( p ‐value >0.5). Also, fewer adverse effects were reported in the crocin group compared to the fluoxetine group.

Conclusion

According to our study, it seems that crocin is effective in treatment of patients with mild to moderate OCD with possibly fewer adverse effects compared to fluoxetine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluoxetineObsessive-Compulsive DisorderCarotenoidsDouble-Blind MethodHumansPsychiatric Status Rating ScalesTreatment Outcome

Stichwörter der Autor:innen

anxietycrocinfluoxetineobsessive-compulsive disorder

Substanzen

FluoxetineCarotenoidscrocin

Autor:innen und Institutionen

  • Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Psychiatry, Ibn-e-Sina Psychiatric Hospital, Mashhad, Iran.
  • Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.

ORCID-Profile: Seyed Ahmad Mohajeri

Förderung

  • Mashhad University of Medical Sciences

Zitieren

APA

Kazemi, F., Vosough, I., Sepahi, S., & Mohajeri, S. A. (2021). Effect of crocin versus fluoxetine in treatment of mild to moderate obsessive‐compulsive disorder: A double blind randomized clinical trial. Human Psychopharmacology: Clinical and Experimental, 36(4). https://doi.org/10.1002/hup.2780

Vancouver

Kazemi F, Vosough I, Sepahi S, Mohajeri SA. Effect of crocin versus fluoxetine in treatment of mild to moderate obsessive‐compulsive disorder: A double blind randomized clinical trial. Human Psychopharmacology: Clinical and Experimental. 2021;36(4). doi:10.1002/hup.2780

BibTeX
@article{Kazemi2021,
  author = {Kazemi, Fatemeh and Vosough, Iraj and Sepahi, Samaneh and Mohajeri, Seyed Ahmad},
  title = {Effect of crocin versus fluoxetine in treatment of mild to moderate obsessive‐compulsive disorder: A double blind randomized clinical trial},
  journal = {Human Psychopharmacology: Clinical and Experimental},
  year = {2021},
  volume = {36},
  number = {4},
  doi = {10.1002/hup.2780}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche